Shilpa Darivemula, MD, MS, Sriya Bhumi, MBA, and Jenn Pamela Chowdhury, MS
Indian classical dance illuminates a collaborative, narrative approach to interrogating ethnic and racial biases in clinical jargon and their roles in inequitable health care practice.
AMA J Ethics. 2021; 23(3):E276-280. doi:
10.1001/amajethics.2021.276.
Clinicians with obligations to patients and to organizations often assess patients in law enforcement for both therapeutic and nontherapeutic purposes.
AMA J Ethics. 2022; 24(2):E111-119. doi:
10.1001/amajethics.2022.111.
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021; 23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
Health educators have duties to teach patient focus, motivate equity, and cultivate students’ capacity to serve our most vulnerable neighbors, wherever they reside.
AMA J Ethics. 2021; 23(11):E858-863. doi:
10.1001/amajethics.2021.858.